Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases

Summary

This is an open clinical pharmacological translational Research Study, aiming to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of RD06-05 in patients with active SLE, SSc, AAV, IIM, NMOSD, MS, MG

Timeline

Start

2025-01-03

Primary completion

2027-01-01

Completion

2027-06-01

Drugs

Indications